The agency has approved the first-ever implantable wireless device with remote monitoring to measure pulmonary artery pressure and heart rate in patients with heart failure.
Doctors will try to save seriously injured patients -– dying patients, actually -– by using the procedure.
The association's Health Care Section is sponsoring the June 11 panel.
The resolution notes the importance of implementing measures to protect vulnerable groups and says there is a need to improve screening.
The number reported this year through April, 1,711, more than tripled the number during the same period in 2013.
The agency has announced it will be requiring a lower starting dose for the sleep drug.
May 13’s decision took place at the fifth meeting of the International Health Regulations Emergency Committee concerning Middle East respiratory syndrome coronavirus. WHO's statement says the committee members did agree their concern about the situation has significantly increased, given the recent spike in cases.
The agency approves Zontivity to reduce the risk of heart attack, stroke and cardiovascular death in high risk patients.
ASTM has formed a task group to develop a specification standard for them, Selcen Kilinc-Balci, a physical scientist for NIOSH's National Personal Protective Technology Laboratory, reported on the agency’s Science Blog.
Dr. Margaret A. Hamburg writes that the states "have an important role to play in addressing a critical driver of opioid abuse -- inappropriate prescribing practices. However, we can't just focus on one drug, Zohydro, alone."
As many as 75 percent of the recent cases are secondary infections -- meaning individuals who became infected through contact with another person. Most of these are health care workers who became infected at work.
The agency proposes extending its authority to other products, including e-cigarettes.
The agency proposes a new expedited access program for medical devices for patients whose conditions are urgent and serious.
Participating agencies have taken more than 1,700 tons of unwanted or expired prescription medications out of circulation during the past three and a half years in this way.
The FDA approves Ragwitek for treatment of short ragweed pollen allergies.
Vaccinations, avoiding mosquitoes, and choosing safe transportation are some of its recommendations.
The agency has set a 60-day comment period for the proposed rule it published April 16. A new provision for existing health care occupancies will require buildings more than 75 feet tall to have automatic sprinkler systems installed throughout the building.
The FDA has approved Tanzeum subcutaneous injection for those living with type 2 diabetes. FDA is requiring post-marketing studies for Tanzeum, including a clinical trial to evaluate dosing, efficacy, and safety in pediatric patients.
JAMA has published a paper by a team led by Drs. Mary Rogers and Jeffrey Rohde of the University of Michigan. They examined the association between two types of transfusion strategies and health care-associated infections.
The Division of Workers' Compensation is accepting public comments until April 21.